2,794 Shares in Astera Labs, Inc. $ALAB Purchased by Wealthfront Advisers LLC

Wealthfront Advisers LLC bought a new position in Astera Labs, Inc. (NASDAQ:ALAB) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 2,794 shares of the company’s stock, valued at approximately $1,350,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. Glenmede Trust Co. NA grew its holdings in shares of Astera Labs by 2.7% during the first quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock valued at $209,000 after purchasing an additional 51 shares during the last quarter. Lido Advisors LLC lifted its holdings in shares of Astera Labs by 0.5% in the 4th quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock worth $2,046,000 after purchasing an additional 57 shares during the last quarter. Goldstein Advisors LLC boosted its position in Astera Labs by 5.8% during the 4th quarter. Goldstein Advisors LLC now owns 1,611 shares of the company’s stock valued at $268,000 after purchasing an additional 88 shares during the period. Bell Investment Advisors Inc acquired a new position in Astera Labs during the 2nd quarter valued at approximately $43,000. Finally, Great Valley Advisor Group Inc. boosted its position in Astera Labs by 2.2% during the 2nd quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock valued at $372,000 after purchasing an additional 90 shares during the period. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, Director Stefan A. Dyckerhoff sold 8,994 shares of the company’s stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $311.83, for a total value of $2,804,599.02. Following the completion of the sale, the director owned 3,970 shares in the company, valued at $1,237,965.10. This represents a 69.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 136,974 shares of the firm’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $442.01, for a total value of $60,543,877.74. Following the transaction, the director directly owned 1,287,524 shares of the company’s stock, valued at $569,098,483.24. This represents a 9.62% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 419,244 shares of company stock worth $163,135,169. 10.40% of the stock is owned by corporate insiders.

Astera Labs Price Performance

NASDAQ ALAB opened at $284.97 on Friday. Astera Labs, Inc. has a 12 month low of $97.89 and a 12 month high of $499.48. The firm has a market capitalization of $49.44 billion, a PE ratio of 141.07 and a beta of 3.84. The company’s 50 day simple moving average is $352.70 and its 200 day simple moving average is $244.92.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The firm had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm’s revenue for the quarter was up 104.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Sell-side analysts anticipate that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on ALAB. Royal Bank Of Canada increased their target price on Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 5th. Jefferies Financial Group upped their price target on shares of Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. Evercore reaffirmed an “outperform” rating and issued a $297.00 price objective on shares of Astera Labs in a report on Tuesday, May 19th. Needham & Company LLC lifted their price objective on shares of Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a research report on Wednesday, August 5th. Finally, Bank of America lifted their price objective on shares of Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a research report on Tuesday, June 23rd. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $333.00.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.